Arrowhead Pharmaceuticals
ARWR
#2176
Rank
ยฃ6.37 B
Marketcap
ยฃ46.08
Share price
-4.98%
Change (1 day)
148.86%
Change (1 year)

Arrowhead Pharmaceuticals (ARWR) - Total liabilities

Total liabilities on the balance sheet as of June 2025 : ยฃ0.64 Billion

According to Arrowhead Pharmaceuticals 's latest financial reports the company's total liabilities are ยฃ0.64 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Arrowhead Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-09-30ยฃ0.70 B80.84%
2023-09-30ยฃ0.39 B59.51%
2022-09-30ยฃ0.24 B9.91%
2021-09-30ยฃ0.22 B375.87%
2020-09-30ยฃ47 M-45.4%
2019-09-30ยฃ86.09 M585.8%
2018-09-30ยฃ12.55 M-27.37%
2017-09-30ยฃ17.28 M-32.42%
2016-09-30ยฃ25.57 M70.81%
2015-09-30ยฃ14.97 M44.24%
2014-09-30ยฃ10.38 M44.92%
2013-09-30ยฃ7.16 M49.64%
2012-09-30ยฃ4.78 M124.89%
2011-09-30ยฃ2.12 M-21.77%
2010-09-30ยฃ2.72 M52.12%
2009-09-30ยฃ1.78 M-36.08%
2008-09-30ยฃ2.79 M68.43%
2007-09-30ยฃ1.66 M6.52%
2006-09-30ยฃ1.55 M168.28%
2005-09-30ยฃ0.58 M51.65%
2004-09-30ยฃ0.38 M564.34%
2003-09-30ยฃ0.05 M-94.42%
2002-09-30ยฃ1.03 M12.76%
2001-09-30ยฃ0.91 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Alnylam Pharmaceuticals
ALNY
ยฃ3.46 B 436.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
ยฃ0.39 B-38.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
ยฃ57.83 M-91.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ85.16 B 13,089.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
ยฃ2.10 B 225.86%๐Ÿ‡บ๐Ÿ‡ธ USA